Overview

Use of Transexamic Acid in Hip Replacement

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Studies have shown that tranexamic acid reduces blood loss and transfusion need in patients undergoing total hip arthroplasty. However, no to date, no study has been large enough to determine definitively whether the drug is safe and effective. The present study was designed to verify noninferior efficacy and safety of topical intra-articular TXA compared with intravenous TXA in primary THA.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Tranexamic Acid